| P50 | author | Dafna D. Gladman | Q37605821 |
| P2093 | author name string | Urowitz MB | |
| | Bruce IN | |
| P2860 | cites work | Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics | Q28300402 |
| | Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus | Q28319260 |
| | Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus | Q77909409 |
| | Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 |
| | Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 |
| | Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations | Q33487732 |
| | Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis | Q35168903 |
| | Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. | Q35171679 |
| | THE CARDIOVASCULAR MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. | Q35456791 |
| | Experimental induction of athero-arteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. I. Effect of repeated injections of horse serum in rabbits fed a dietary cholesterol supplement | Q36268330 |
| | Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis | Q36747001 |
| | A critical review of the relationship between impaired fibrinolysis and myocardial infarction | Q37202358 |
| | An update on coronary risk factors | Q40482679 |
| | Is atherosclerosis an immunologically mediated disease? | Q40606541 |
| | Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular disease | Q41288539 |
| | Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis | Q41537096 |
| | Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 |
| | Some health benefits of physical activity. The Framingham Study | Q41722154 |
| | Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids | Q41943371 |
| | Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q43492677 |
| | The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 |
| | The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients | Q44593960 |
| | The atherogenic effect of lupus sera: Systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta | Q45129182 |
| | Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. | Q47841056 |
| | Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. | Q51017150 |
| | Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. | Q51577475 |
| | Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. | Q51578946 |
| | Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. | Q51584611 |
| | Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. | Q51590158 |
| | Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus | Q60680877 |
| | Risk factors for coronary artery disease in patients with systemic lupus erythematosus | Q67586359 |
| | Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response | Q69068473 |
| | Ischemic heart disease in systemic lupus erythematosus. A retrospective study of 65 patients treated with prednisolone | Q69387458 |
| | Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids | Q69414146 |
| | Systemic lupus erythematosus and acute myocardial infarction | Q69604022 |
| | Hyperhomocysteinemia: an independent risk factor for vascular disease | Q70131136 |
| | Dyslipoproteinemia in pediatric systemic lupus erythematosus | Q70396550 |
| | Insulin resistance and atherosclerosis | Q71351489 |
| | Subclinical Disease as an Independent Risk Factor for Cardiovascular Disease | Q71974433 |
| | Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study | Q72573690 |
| | Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus | Q72607855 |
| | Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 |
| | Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus | Q73723971 |
| | Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction | Q73965948 |
| | Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice | Q77748422 |
| P433 | issue | 2 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| | atherosclerosis | Q12252367 |
| P304 | page(s) | 257-278 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Rheumatic Diseases Clinics of North America | Q7320483 |
| P1476 | title | Premature atherosclerosis in systemic lupus erythematosus. | |
| P478 | volume | 26 | |